US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 32.360
  • -0.100-0.31%
Close Feb 14 16:00 ET
14.02BMarket Cap16.94P/E (TTM)

Royalty Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.32%2.77B
-3.90%742.53M
22.68%703.61M
8.29%658.21M
-35.71%664.64M
39.36%2.99B
35.57%772.63M
6.44%573.52M
5.72%607.82M
124.62%1.03B
Net income from continuing operations
-21.72%1.33B
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
638.96%1.7B
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
Operating gains losses
6.88%-2.37B
13.57%-593.6M
-30.08%-655.1M
21.74%-513.66M
13.00%-605.13M
-17.05%-2.54B
-31.83%-686.82M
4.19%-503.6M
-1.03%-656.35M
-46.20%-695.57M
Depreciation and amortization
--0
----
----
----
----
--0
----
----
----
----
Other non cash items
-7.36%3B
2.06%785.69M
11.78%798.16M
11.53%667.88M
-35.15%752.35M
30.43%3.24B
19.00%769.85M
7.93%714.03M
7.29%598.84M
87.23%1.16B
Change In working capital
891.88%53.38M
7.53%51.52M
49.43%-18.72M
33.09%50.08M
31.62%-29.5M
-83.52%5.38M
92.04%47.91M
-19.51%-37.02M
-52.00%37.63M
-8.62%-43.14M
-Change in receivables
-199.21%-4.55M
-141.20%-2.06M
50.76%-1.32M
-142.10%-1.35M
114.83%178K
67.94%-1.52M
97.77%-852K
-632.34%-2.68M
-89.45%3.21M
-147.98%-1.2M
-Change in payables and accrued expense
1,073.86%44.09M
23.14%53.78M
71.84%-10.64M
8.92%43.65M
-1.16%-42.7M
400.96%3.76M
33.32%43.67M
-2.04%-37.78M
-13.77%40.08M
2.86%-42.21M
-Change in other current assets
339.91%13.84M
-84.75%776K
-178.60%-2.7M
148.51%2.74M
4,637.45%13.03M
-91.86%3.15M
-83.26%5.09M
-37.93%3.44M
-485.09%-5.66M
-77.86%275K
-Change in other current liabilities
----
----
---4.06M
----
----
----
----
--0
----
----
Cash from discontinued investing activities
Operating cash flow
-7.32%2.77B
-3.90%742.53M
22.68%703.61M
8.29%658.21M
-35.71%664.64M
39.36%2.99B
35.57%772.63M
6.44%573.52M
5.72%607.82M
124.62%1.03B
Investing cash flow
Cash flow from continuing investing activities
-29.20%-2.68B
49.45%-505.59M
-164.66%-1.19B
-1,308.06%-893.18M
84.49%-86.65M
-101.35%-2.07B
-341.16%-1B
68.38%-450.66M
-110.20%-63.43M
-5,102.47%-558.53M
Net business purchase and sale
12.65%-10.96M
--0
--0
-33.38%-3.98M
-94.78%-6.97M
-26.74%-12.54M
---1.99M
41.81%-3.98M
---2.99M
-17.34%-3.58M
Net investment purchase and sale
-25.27%-2.62B
51.66%-483.83M
-166.93%-1.2B
-1,298.23%-845.17M
85.34%-84.64M
-104.97%-2.09B
-341.31%-1B
68.19%-451.13M
-100.30%-60.45M
-4,161.30%-577.31M
Net other investing changes
-405.34%-72.96M
-1,126.69%-25M
--1K
----
----
---14.44M
---2.04M
--0
--0
---12.4M
Cash from discontinued investing activities
Investing cash flow
-29.20%-2.68B
49.45%-505.59M
-164.66%-1.19B
-1,308.06%-893.18M
84.49%-86.65M
-101.35%-2.07B
-341.16%-1B
68.38%-450.66M
-110.20%-63.43M
-5,102.47%-558.53M
Financing cash flow
Cash flow from continuing financing activities
116.81%361.15M
-11.24%-257.96M
76.06%-325.51M
433.32%1.16B
-0.77%-212M
-127.42%-2.15B
12.67%-231.89M
-490.86%-1.36B
-52.02%-347M
4.79%-210.37M
Net issuance payments of debt
247.12%1.47B
--0
--0
----
----
---1B
--0
---1B
----
----
Net common stock issuance
24.65%-229.65M
-74.20%-52.61M
30.74%-97.05M
----
----
---304.76M
---30.2M
---140.12M
----
----
Cash dividends paid
-5.06%-376.47M
-4.83%-93.66M
-4.80%-94.06M
-4.79%-94.94M
-5.84%-93.81M
-7.50%-358.33M
-6.10%-89.34M
-7.09%-89.75M
-9.10%-90.61M
-7.74%-88.63M
Net other financing activities
-3.77%-503.97M
0.58%-111.7M
-3.68%-134.4M
-14.54%-139.68M
2.91%-118.19M
20.58%-485.67M
38.04%-112.36M
11.39%-129.62M
16.02%-121.95M
12.23%-121.74M
Cash from discontinued financing activities
Financing cash flow
116.81%361.15M
-11.24%-257.96M
76.06%-325.51M
433.32%1.16B
-0.77%-212M
-127.42%-2.15B
12.67%-231.89M
-490.86%-1.36B
-52.02%-347M
4.79%-210.37M
Net cash flow
Beginning cash position
-72.12%477.01M
1.45%950.05M
-18.80%1.76B
-57.33%843M
-72.12%477.01M
11.01%1.71B
-5.56%936.45M
3.09%2.17B
10.28%1.98B
11.01%1.71B
Current changes in cash
136.64%452.02M
95.42%-21.03M
34.13%-814.59M
366.92%921.64M
38.14%365.99M
-827.00%-1.23B
-163.89%-459.44M
-10.77%-1.24B
-37.64%197.39M
5.78%264.94M
End cash Position
94.76%929.03M
94.76%929.03M
1.45%950.05M
-18.80%1.76B
-57.33%843M
-72.12%477.01M
-72.12%477.01M
-5.56%936.45M
3.09%2.17B
10.28%1.98B
Free cash flow
-7.32%2.77B
-3.90%742.53M
22.68%703.61M
8.29%658.21M
-35.71%664.64M
39.36%2.99B
35.57%772.63M
6.44%573.52M
5.72%607.82M
124.62%1.03B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.32%2.77B-3.90%742.53M22.68%703.61M8.29%658.21M-35.71%664.64M39.36%2.99B35.57%772.63M6.44%573.52M5.72%607.82M124.62%1.03B
Net income from continuing operations -21.72%1.33B-53.41%334.35M560.53%806.36M-44.67%194.38M-100.84%-4.27M638.96%1.7B217.63%717.59M-44.61%122.08M-28.53%351.34M297.47%509.09M
Operating gains losses 6.88%-2.37B13.57%-593.6M-30.08%-655.1M21.74%-513.66M13.00%-605.13M-17.05%-2.54B-31.83%-686.82M4.19%-503.6M-1.03%-656.35M-46.20%-695.57M
Depreciation and amortization --0------------------0----------------
Other non cash items -7.36%3B2.06%785.69M11.78%798.16M11.53%667.88M-35.15%752.35M30.43%3.24B19.00%769.85M7.93%714.03M7.29%598.84M87.23%1.16B
Change In working capital 891.88%53.38M7.53%51.52M49.43%-18.72M33.09%50.08M31.62%-29.5M-83.52%5.38M92.04%47.91M-19.51%-37.02M-52.00%37.63M-8.62%-43.14M
-Change in receivables -199.21%-4.55M-141.20%-2.06M50.76%-1.32M-142.10%-1.35M114.83%178K67.94%-1.52M97.77%-852K-632.34%-2.68M-89.45%3.21M-147.98%-1.2M
-Change in payables and accrued expense 1,073.86%44.09M23.14%53.78M71.84%-10.64M8.92%43.65M-1.16%-42.7M400.96%3.76M33.32%43.67M-2.04%-37.78M-13.77%40.08M2.86%-42.21M
-Change in other current assets 339.91%13.84M-84.75%776K-178.60%-2.7M148.51%2.74M4,637.45%13.03M-91.86%3.15M-83.26%5.09M-37.93%3.44M-485.09%-5.66M-77.86%275K
-Change in other current liabilities -----------4.06M------------------0--------
Cash from discontinued investing activities
Operating cash flow -7.32%2.77B-3.90%742.53M22.68%703.61M8.29%658.21M-35.71%664.64M39.36%2.99B35.57%772.63M6.44%573.52M5.72%607.82M124.62%1.03B
Investing cash flow
Cash flow from continuing investing activities -29.20%-2.68B49.45%-505.59M-164.66%-1.19B-1,308.06%-893.18M84.49%-86.65M-101.35%-2.07B-341.16%-1B68.38%-450.66M-110.20%-63.43M-5,102.47%-558.53M
Net business purchase and sale 12.65%-10.96M--0--0-33.38%-3.98M-94.78%-6.97M-26.74%-12.54M---1.99M41.81%-3.98M---2.99M-17.34%-3.58M
Net investment purchase and sale -25.27%-2.62B51.66%-483.83M-166.93%-1.2B-1,298.23%-845.17M85.34%-84.64M-104.97%-2.09B-341.31%-1B68.19%-451.13M-100.30%-60.45M-4,161.30%-577.31M
Net other investing changes -405.34%-72.96M-1,126.69%-25M--1K-----------14.44M---2.04M--0--0---12.4M
Cash from discontinued investing activities
Investing cash flow -29.20%-2.68B49.45%-505.59M-164.66%-1.19B-1,308.06%-893.18M84.49%-86.65M-101.35%-2.07B-341.16%-1B68.38%-450.66M-110.20%-63.43M-5,102.47%-558.53M
Financing cash flow
Cash flow from continuing financing activities 116.81%361.15M-11.24%-257.96M76.06%-325.51M433.32%1.16B-0.77%-212M-127.42%-2.15B12.67%-231.89M-490.86%-1.36B-52.02%-347M4.79%-210.37M
Net issuance payments of debt 247.12%1.47B--0--0-----------1B--0---1B--------
Net common stock issuance 24.65%-229.65M-74.20%-52.61M30.74%-97.05M-----------304.76M---30.2M---140.12M--------
Cash dividends paid -5.06%-376.47M-4.83%-93.66M-4.80%-94.06M-4.79%-94.94M-5.84%-93.81M-7.50%-358.33M-6.10%-89.34M-7.09%-89.75M-9.10%-90.61M-7.74%-88.63M
Net other financing activities -3.77%-503.97M0.58%-111.7M-3.68%-134.4M-14.54%-139.68M2.91%-118.19M20.58%-485.67M38.04%-112.36M11.39%-129.62M16.02%-121.95M12.23%-121.74M
Cash from discontinued financing activities
Financing cash flow 116.81%361.15M-11.24%-257.96M76.06%-325.51M433.32%1.16B-0.77%-212M-127.42%-2.15B12.67%-231.89M-490.86%-1.36B-52.02%-347M4.79%-210.37M
Net cash flow
Beginning cash position -72.12%477.01M1.45%950.05M-18.80%1.76B-57.33%843M-72.12%477.01M11.01%1.71B-5.56%936.45M3.09%2.17B10.28%1.98B11.01%1.71B
Current changes in cash 136.64%452.02M95.42%-21.03M34.13%-814.59M366.92%921.64M38.14%365.99M-827.00%-1.23B-163.89%-459.44M-10.77%-1.24B-37.64%197.39M5.78%264.94M
End cash Position 94.76%929.03M94.76%929.03M1.45%950.05M-18.80%1.76B-57.33%843M-72.12%477.01M-72.12%477.01M-5.56%936.45M3.09%2.17B10.28%1.98B
Free cash flow -7.32%2.77B-3.90%742.53M22.68%703.61M8.29%658.21M-35.71%664.64M39.36%2.99B35.57%772.63M6.44%573.52M5.72%607.82M124.62%1.03B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
Alibaba Group Q4 FY2024 earnings conference call
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.